Matthew L. Sherman, EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 984 shares at $9.05 ($9K) on 2022-02-16, disclosed to the SEC on 2022-02-18.
Open-market sale of $9k DCPH by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |